STONE BENJAMIN
SEC insider (Form 3/4/5 filer). CIK 0002128786. Chief Business Officer at First Tracks Biotherapeutics, Inc. (TRAX). 4 reported Form 4/5 transactions since Sep 2024; latest on Aug 15, 2026. Located in SAN DIEGO, CA.
Companies STONE BENJAMIN has filed insider reports for
- First Tracks Biotherapeutics, Inc. (TRAX): Officer, Chief Business Officer
STONE BENJAMIN
CIK: 0002128786
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
First Tracks Biotherapeutics, Inc.
Discretionary Trading P&L
Holdings
Transaction History (4 total)
- Aug 15, 2026TRAX
First Tracks Biotherapeutics, Inc.
AwardDirectPerformance Stock Units
60.5K shares- - Aug 2, 2026TRAX
First Tracks Biotherapeutics, Inc.
AwardDirectPerformance Stock Units
60.5K shares- - May 12, 2026TRAX
First Tracks Biotherapeutics, Inc.
AwardDirectRestricted Stock Unit
26.7K shares- - May 12, 2026TRAX
First Tracks Biotherapeutics, Inc.
AwardDirectEmployee Stock Option (right to buy)
72.3K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Aug 15, 2026 | TRAX First Tracks Biotherapeutics, Inc. | Award Performance Stock Units | 60,492 | - | - | Direct |
| Aug 2, 2026 | TRAX First Tracks Biotherapeutics, Inc. | Award Performance Stock Units | 60,492 | - | - | Direct |
| May 12, 2026 | TRAX First Tracks Biotherapeutics, Inc. | Award Restricted Stock Unit | 26,700 | - | - | Direct |
| May 12, 2026 | TRAX First Tracks Biotherapeutics, Inc. | Award Employee Stock Option (right to buy) | 72,300 | - | - | Direct |
1-4 of 4 transactions